These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15923846)

  • 1. Radiation-induced craniofacial bone growth inhibition: efficacy of cytoprotection following a fractionated dose regimen.
    La Scala GC; O'Donovan DA; Yeung I; Darko J; Addison PD; Neligan PC; Pang CY; Forrest CR
    Plast Reconstr Surg; 2005 Jun; 115(7):1973-85. PubMed ID: 15923846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of radioprotection in the prevention of radiation-induced craniofacial bone growth inhibition.
    Forrest CR; O'Donovan DA; Yeung I; Zeman V; La Scala G; Neligan PC; Pang CY
    Plast Reconstr Surg; 2002 Apr; 109(4):1311-23; discussion 1324. PubMed ID: 11964983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced craniofacial bone growth inhibition: acute and long-term effects on bone histopathology with and without cytoprotection.
    O'Donovan DA; La Scala GC; Leong I; Mendes M; Rogers M; Pritzker KH; Yeung I; Pang CY; Neligan PC; Forrest CR
    Plast Reconstr Surg; 2012 Apr; 129(4):636e-645e. PubMed ID: 22456377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced craniofacial bone growth inhibition: development of an animal model.
    O'Donovan DA; Yeung I; Zeman V; Neligan PC; Pang CY; Forrest CR
    J Craniofac Surg; 2001 Nov; 12(6):533-43. PubMed ID: 11711819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced craniofacial bone growth inhibition: in vitro cytoprotection in the rabbit orbitozygomatic complex periosteum-derived cell culture.
    Gevorgyan AM; La Scala GC; Sukhu B; Leung IT; Ashrafpour H; Yeung I; Neligan PC; Pang CY; Forrest CR
    Plast Reconstr Surg; 2008 Mar; 121(3):763-771. PubMed ID: 18317126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local hemodynamic effects of radiation on the rabbit orbitozygomatic complex with and without cytoprotection.
    La Scala GC; O'Donovan DA; Yeung I; Leong I; Mendes M; Rogers M; Neligan PC; Pang CY; Forrest CR
    Plast Reconstr Surg; 2012 Mar; 129(3):599-608. PubMed ID: 22373966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioprotection of craniofacial bone growth.
    Gevorgyan A; La Scala GC; Neligan PC; Pang CY; Forrest CR
    J Craniofac Surg; 2007 Sep; 18(5):995-1000. PubMed ID: 17912071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro model of radiation-induced craniofacial bone growth inhibition.
    Gevorgyan A; La Scala GC; Sukhu B; Leung IT; Ashrafpour H; Yeung I; Neligan PC; Pang CY; Forrest CR
    J Craniofac Surg; 2007 Sep; 18(5):1044-50. PubMed ID: 17912079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amifostine before fractionated irradiation protects bone growth in rats better than fractionation alone.
    Damron TA; Margulies B; Biskup D; Spadaro JA
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):479-83. PubMed ID: 11380237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced craniofacial bone growth disturbances.
    Gevorgyan A; La Scala GC; Neligan PC; Pang CY; Forrest CR
    J Craniofac Surg; 2007 Sep; 18(5):1001-7. PubMed ID: 17912072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sparing of radiation-induced damage to the physis: fractionation alone compared to amifostine pretreatment.
    Damron TA; Spadaro JA; Tamurian RM; Damron LA
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1067-71. PubMed ID: 10863080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative histologic evidence of amifostine-induced cytoprotection in an irradiated murine model of mandibular distraction osteogenesis.
    Tchanque-Fossuo CN; Donneys A; Razdolsky ER; Monson LA; Farberg AS; Deshpande SS; Sarhaddi D; Poushanchi B; Goldstein SA; Buchman SR
    Plast Reconstr Surg; 2012 Dec; 130(6):1199-1207. PubMed ID: 22878481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic administration of Amifostine protects vessel thickness in the setting of irradiated bone.
    Page EE; Deshpande SS; Nelson NS; Felice PA; Donneys A; Rodriguez JJ; Deshpande SS; Buchman SR
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):98-103. PubMed ID: 25216566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation.
    Braaksma M; Levendag P
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):63-70. PubMed ID: 12577248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
    Altmann S; Hoffmanns H
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
    Vujaskovic Z; Feng QF; Rabbani ZN; Samulski TV; Anscher MS; Brizel DM
    Exp Lung Res; 2002; 28(7):577-90. PubMed ID: 12396250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of protective effects of L-carnitine and amifostine on radiation-induced toxicity to growing bone: histopathology and scintigraphy findings.
    Yurut-Caloglu V; Durmus-Altun G; Caloglu M; Usta U; Saynak M; Uzal C; Cosar-Alas R; Kocak Z
    Asian Pac J Cancer Prev; 2010; 11(3):661-7. PubMed ID: 21039033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological and scintigraphic comparisons of the protective effects of L-carnitine and amifostine against radiation-induced late renal toxicity in rats.
    Caloglu M; Yurut-Caloglu V; Durmus-Altun G; Oz-Puyan F; Ustun F; Cosar-Alas R; Saynak M; Parlar S; Turan FN; Uzal C
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):523-30. PubMed ID: 19673935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.
    Anné PR
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):80-3. PubMed ID: 12577250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer.
    Büntzel J; Küttner K; Fröhlich D; Glatzel M
    Ann Oncol; 1998 May; 9(5):505-9. PubMed ID: 9653491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.